BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q3 2024 investor call Friday, November 15th at 10 a.m. ET. Results will be released after the market close on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session.
Conference Details
Date / Time:    Friday, November 15th at 10 a.m. ET
Call Dial In #:   1-877-418-5460 U.S. or 1-412-717-9594 Int’l
Live Webcast / Replay:   Webcast & Replay Link – Available for 3 months.
Audio Replay:   1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 7307131
     

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over 40 million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

Engage with BIO-key
Facebook – Corporate:   https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate:   https://www.linkedin.com/company/bio-key-international
X – Corporate:   @BIOkeyIntl
X – Investors:   @BIO_keyIR
StockTwits:   BIO_keyIR
     

Investor ContactsWilliam Jones, David CollinsCatalyst IRBKYI@catalyst-ir.com212-924-9800

BIO key (NASDAQ:BKYI)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos BIO key.
BIO key (NASDAQ:BKYI)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos BIO key.